Other authors have shown a neuroprotective effect of mGluR2/3 agonists against different cytotoxic molecules in neuronal cells, including undifferentiated and differentiated neuroblastoma cells, by avoiding decreases in cell viability. Here, GRM2 is linked to neuroblastoma.